{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:28:49Z","timestamp":1791606529055,"version":"4.3.4"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T00:00:00Z","timestamp":1529107200000},"content-version":"am","delay-in-days":288,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006379","name":"appointment to the Internship\/Research Participation Program at the Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000139","name":"U.S. Environmental Protection Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000139","name":"EPA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environment International"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.envint.2017.06.004","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T04:19:29Z","timestamp":1497673169000},"page":"105-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"special_numbering":"C","title":["Identifying populations sensitive to environmental chemicals by simulating toxicokinetic variability"],"prefix":"10.1016","volume":"106","author":[{"given":"Caroline L.","family":"Ring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Woodrow","family":"Setzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Wetmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Wambaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.envint.2017.06.004_bb0005","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1289\/ehp.1408775","article-title":"Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening study","volume":"123","author":"Abdo","year":"2015","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2017.06.004_bb0010","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/jat.1626","article-title":"Consideration of dosimetry in evaluation of ToxCast\u2122 data","volume":"31","author":"Aylward","year":"2011","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.envint.2017.06.004_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/138920007779315053","article-title":"Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human micro-somal protein and hepatocellularity per gram of liver","volume":"8","author":"Barter","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.envint.2017.06.004_bb0020","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1124\/dmd.108.021311","article-title":"Covariation of human microsomal protein per gram of liver with age: absence of influence of operator and sample storage may justify interlaboratory data pooling","volume":"36","author":"Barter","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.envint.2017.06.004_bb0025","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.412","article-title":"Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass","volume":"26","author":"Baxter-Jones","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.envint.2017.06.004_bb0030","article-title":"Genetic factors in drug metabolism","volume":"77","author":"Belle","year":"2008","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.envint.2017.06.004_bb0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1634\/theoncologist.11-2-126","article-title":"Interethnic differences in genetic polymorphisms of CYP2D6 in the US population: clinical implications","volume":"11","author":"Bernard","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.envint.2017.06.004_bb0040","series-title":"Physiological Parameter Values for PBPK Models","author":"Birnbaum","year":"1994"},{"key":"10.1016\/j.envint.2017.06.004_bb0045","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3109\/10408444.2012.709225","article-title":"An improved model to predict physiologically based model parameters and their inter-individual variability from anthropometry","volume":"42","author":"Bosgra","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.envint.2017.06.004_bb0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2133\/dmpk.DMPK-11-RG-078","article-title":"Inter-individual variability of in vivo CYP2D6 activity in different genotypes","volume":"27","author":"Chiba","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.envint.2017.06.004_bb0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2133\/dmpk.DMPK-13-RG-137","article-title":"Prediction of inter-individual variability in the pharmacokinetics of CYP2C19 substrates in humans","volume":"29","author":"Chiba","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.envint.2017.06.004_bb0060","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3109\/00498254.2011.560294","article-title":"Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model","volume":"41","author":"Cubitt","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.envint.2017.06.004_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/toxsci\/66.2.185","article-title":"Evaluation of child\/adult pharmacokinetic differences from a database derived from the therapeutic drug literature","volume":"66","author":"Ginsberg","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2017.06.004_bb0070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1289\/ehp.6013","article-title":"Incorporating Children's Toxicokinetics into a risk framework","volume":"112","author":"Ginsberg","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2017.06.004_bb9500","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1289\/ehp.7568","article-title":"Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals","author":"Ginsberg","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2017.06.004_bb0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.envsoft.2012.03.014","article-title":"Estimating Sobol sensitivity indices using correlations","volume":"37","author":"Glen","year":"2012","journal-title":"Environ. Model Softw."},{"key":"10.1016\/j.envint.2017.06.004_bb0080","series-title":"Use of World Health Organization and CDC Growth Charts for Children Aged 0\u201359 Months in the United States","author":"Grummer-Strawn","year":"2010"},{"key":"10.1016\/j.envint.2017.06.004_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3476(78)80601-5","article-title":"Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults","volume":"93","author":"Haycock","year":"1978","journal-title":"J. Pediatr."},{"key":"10.1016\/j.envint.2017.06.004_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jbt.20179","article-title":"Ontogeny of human hepatic cytochromes P450","volume":"21","author":"Hines","year":"2007","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.envint.2017.06.004_bb0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2133\/dmpk.DMPK-11-RV-090","article-title":"In vitro assessment of the allelic variants of cytochrome P450","volume":"27","author":"Hiratsuka","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.envint.2017.06.004_bb0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/00498250600683197","article-title":"Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability","volume":"36","author":"Howgate","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1016\/j.envint.2017.06.004_bb0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/00498250600683262","article-title":"Prediction of in vivo drug clearance from in vitro data. II: potential inter-ethnic differences","volume":"36","author":"Inoue","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1016\/j.envint.2017.06.004_bb0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1081\/DMR-100104402","article-title":"Human alpha-1-glycoprotein and its interations with drugs","volume":"33","author":"Israili","year":"2001","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.envint.2017.06.004_bb0115","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.ress.2005.11.047","article-title":"Sensitivity analysis in presence of model uncertainty and correlated inputs","volume":"91","author":"Jacques","year":"2006","journal-title":"Reliab. Eng. Syst. Saf."},{"key":"10.1016\/j.envint.2017.06.004_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2133\/dmpk.24.53","volume":"24","author":"Jamei","year":"2009","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.envint.2017.06.004_bb0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/17425250802691074","article-title":"The Simcyp\u00ae population-based ADME simulator","volume":"5","author":"Jamei","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.envint.2017.06.004_bb0130","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2165\/00003088-200645090-00005","article-title":"Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children","volume":"45","author":"Johnson","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.envint.2017.06.004_bb0135","first-page":"1","article-title":"National health and nutrition examination survey: analytic guidelines, 1999-2010. Vital and health statistics Series 2","author":"Johnson","year":"2013","journal-title":"Data Eval. Methods Res."},{"key":"10.1016\/j.envint.2017.06.004_bb0140","first-page":"1","article-title":"National health and nutrition examination survey: sample design, 2011-2014. Vital and health statistics Series 2","author":"Johnson","year":"2014","journal-title":"Data Eval. Methods Res."},{"key":"10.1016\/j.envint.2017.06.004_bb0145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/tx100428e","article-title":"Estimating toxicity-related biological pathway altering doses for high-throughput chemical risk assessment","volume":"24","author":"Judson","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.envint.2017.06.004_bb0150","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2133\/dmpk.DMPK-09-RG-038","article-title":"Prediction of interindividual variability in pharmacokinetics for CYP3A4 substrates in humans","volume":"25","author":"Kato","year":"2010","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.envint.2017.06.004_bb0155","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1021\/tx3000939","article-title":"Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management","volume":"25","author":"Kavlock","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.envint.2017.06.004_bb0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1191\/0748233701th119oa","article-title":"Application of in vitro biotransformation data and pharmacokinetic modeling to risk assessment","volume":"17","author":"Kedderis","year":"2001","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.envint.2017.06.004_bb0165","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1093\/jn\/130.9.2188","article-title":"Body composition in human infants at birth and postnatally","volume":"130","author":"Koo","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.envint.2017.06.004_bb0170","first-page":"1","article-title":"2000 CDC growth charts for the United States: methods and development","volume":"246","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat. Series 11, Data from the national health survey"},{"key":"10.1016\/j.envint.2017.06.004_bb0175","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.envint.2017.06.004_bb0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0048-9697(01)01115-9","article-title":"Incorporating human interindividual biotransformation variance in health risk assessment","volume":"288","author":"Lipscomb","year":"2002","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.envint.2017.06.004_bb0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/15376510309821","article-title":"Variance of microsomal protein and cytochrome P450 2E1 and 3A forms in adult human liver","volume":"13","author":"Lipscomb","year":"2003","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.envint.2017.06.004_bb0190","series-title":"Vital and health statistics Series 11, Data from the National Health Survey","first-page":"1","article-title":"Total body bone area, bone mineral content, and bone mineral density for individuals aged 8 years and over: United States, 1999-2006","author":"Looker","year":"2013"},{"key":"10.1016\/j.envint.2017.06.004_bb0195","series-title":"Hematology of Infancy and Childhood","article-title":"Reference values in infancy and childhood","author":"Lubin","year":"1987"},{"key":"10.1016\/j.envint.2017.06.004_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v009.i08","article-title":"Analysis of complex survey samples","volume":"9","author":"Lumley","year":"2004","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.envint.2017.06.004_bb0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clpt.2006.03.003","article-title":"Genetic polymorphism of cytochrome P450 2C19 in Mexican Americans: a cross-ethnic comparative study","volume":"80","author":"Luo","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2017.06.004_bb0210","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/ajhp\/59.21.2061","article-title":"Genetic basis of drug metabolism","volume":"59","author":"Ma","year":"2002","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.envint.2017.06.004_bb0215","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tox.2013.07.009","article-title":"PopGen: a virtual human population generator","volume":"315","author":"McNally","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.envint.2017.06.004_bb0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1081\/DMR-120023681","article-title":"PM frequencies of major CYPs in Asians and Caucasians","volume":"35","author":"Mizutani","year":"2003","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.envint.2017.06.004_bb0225","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1124\/dmd.108.020479","article-title":"Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds","volume":"36","author":"Obach","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.envint.2017.06.004_bb0230","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011-2012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.envint.2017.06.004_bb0235","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00004032-199703000-00004","article-title":"A statistical analysis of the internal organ weights of normal Japanese people","volume":"72","author":"Ogiu","year":"1997","journal-title":"Health Phys."},{"key":"10.1016\/j.envint.2017.06.004_bb0240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tox.2012.02.007","article-title":"High-performance metabolic profiling of plasma from seven mammalian species for simultaneous environmental chemical surveillance and bioeffect monitoring","volume":"295","author":"Park","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.envint.2017.06.004_bb0245","article-title":"httk: R package for high-throughput toxicokinetics","author":"Pearce","year":"2016","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.envint.2017.06.004_bb0250","series-title":"Instructions for Use of Software Physiological Parameters for PBPK Modeling Version 1.3 (P3MTM 1.3)","author":"Price","year":"2003"},{"key":"10.1016\/j.envint.2017.06.004_bb0255","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/10408440390242324","article-title":"Modeling interindividual variation in physiological factors used in PBPK models of humans","volume":"33","author":"Price","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.envint.2017.06.004_bb0260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.envint.2015.12.008","article-title":"Linking high resolution mass spectrometry data with exposure and toxicity forecasts to advance high-throughput environmental monitoring","volume":"88","author":"Rager","year":"2016","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2017.06.004_bb0265","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/toxsci\/kfq220","article-title":"Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening","volume":"117","author":"Rotroff","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2017.06.004_bb0270","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2125.1986.tb02927.x","article-title":"The plasma protein binding of basic drugs","volume":"22","author":"Routledge","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.envint.2017.06.004_bb0275","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cpc.2009.09.018","article-title":"Variance based sensitivity analysis of model output. Design and estimator for the total sensitivity index","volume":"181","author":"Saltelli","year":"2010","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.envint.2017.06.004_bb0280","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.tiv.2007.09.010","article-title":"General approach for the calculation of tissue to plasma partition coefficients","volume":"22","author":"Schmitt","year":"2008","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.envint.2017.06.004_bb0285","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2215\/CJN.01640309","article-title":"Measurement and estimation of GFR in children and adolescents","volume":"4","author":"Schwartz","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.envint.2017.06.004_bb0290","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/00498254.2010.500407","article-title":"Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds","volume":"40","author":"Sohlenius-Sternbeck","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1016\/j.envint.2017.06.004_bb0295","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/gim.0b013e3182329870","article-title":"Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory","volume":"14","author":"Strom","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.envint.2017.06.004_bb0300","series-title":"High-Throughput Pharmacokinetic Modeling Using Computationally Predicted Parameter Values: Dissociation Constants","author":"Strope","year":"2015"},{"key":"10.1016\/j.envint.2017.06.004_bb0305","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1080\/15287390600631367","article-title":"Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform","volume":"69","author":"Tan","year":"2006","journal-title":"J. Toxic. Environ. Health A"},{"key":"10.1016\/j.envint.2017.06.004_bb0310","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.jes.7500540","article-title":"Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling","volume":"17","author":"Tan","year":"2007","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.envint.2017.06.004_bb0315","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kft178","article-title":"Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework","volume":"136","author":"Thomas","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2017.06.004_bb0320","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00204-011-0768-0","article-title":"Screening of chemicals for human bioaccumulative potential with a physiologically based toxicokinetic model","volume":"86","author":"Tonnelier","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.envint.2017.06.004_bb0325","series-title":"Integrated Bioactivity and Exposure Ranking: A Computational Approach for the Prioritization and Screening of Chemicals in the Endocrine Disruptor Screening Program","author":"USEPA","year":"2014"},{"key":"10.1016\/j.envint.2017.06.004_bb0330","series-title":"EPI (Estimation Programs Interface) Suite","author":"USEPA","year":"2015"},{"key":"10.1016\/j.envint.2017.06.004_bb0335","series-title":"Toxic Substances: EPA Has Increased Efforts to Assess and Control Chemicals but Could Strengthen Its Approach","author":"USGAO","year":"2013"},{"key":"10.1016\/j.envint.2017.06.004_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0146-6453(03)00002-2","article-title":"Basic anatomical and physiological data for use in radiological protection: reference values: ICRP publication 89","volume":"32","author":"Valentin","year":"2002","journal-title":"Ann. ICRP"},{"key":"10.1016\/j.envint.2017.06.004_bb0345","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.metabol.2005.11.004","article-title":"Body surface area in normal-weight, overweight, and obese adults. A comparison study","volume":"55","author":"Verbraecken","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.envint.2017.06.004_bb0350","first-page":"8479","article-title":"High-throughput models for exposure-based chemical prioritization in the ExpoCast project","volume":"47","author":"Wambaugh","year":"2013","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.envint.2017.06.004_bb0355","doi-asserted-by":"crossref","first-page":"12760","DOI":"10.1021\/es503583j","article-title":"High throughput heuristics for prioritizing human exposure to environmental chemicals","volume":"48","author":"Wambaugh","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.envint.2017.06.004_bb0360","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/toxsci\/kfv118","article-title":"Toxicokinetic triage for environmental chemicals","volume":"147","author":"Wambaugh","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2017.06.004_bb9505","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrd2353","article-title":"Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery","volume":"7","author":"Wasan","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.envint.2017.06.004_bb0365","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s13539-011-0042-6","article-title":"Age-and gender-dependent values of skeletal muscle mass in healthy children and adolescents","volume":"3","author":"Webber","year":"2012","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.envint.2017.06.004_bb0370","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/toxsci\/kfr254","article-title":"Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment","volume":"125","author":"Wetmore","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2017.06.004_bb0375","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/toxsci\/kfu169","article-title":"Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing","volume":"142","author":"Wetmore","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2017.06.004_bb0380","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/toxsci\/kfv171","article-title":"Incorporating high-throughput exposure predictions with Dosimetry-adjusted in vitro bioactivity to inform chemical toxicity testing","volume":"148","author":"Wetmore","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2017.06.004_bb0385","series-title":"WHO Child Growth Standards: Length\/Height-for-Age, Weight-for-Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age: Methods and Development","author":"WHO","year":"2006"},{"key":"10.1016\/j.envint.2017.06.004_bb0390","series-title":"WHO Anthro for Personal Computers Manual: Software for Assessing Growth and Development of the World's Children, Version 3.2.2, 2011","author":"WHO","year":"2010"},{"key":"10.1016\/j.envint.2017.06.004_bb0395","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cpt1975184377","article-title":"Commentary: a physiological approach to hepatic drug clearance","volume":"18","author":"Wilkinson","year":"1975","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2017.06.004_bb0400","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-007-9053-5","article-title":"Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs","volume":"34","author":"Willmann","year":"2007","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.envint.2017.06.004_bb0405","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/clpt.2008.141","article-title":"The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies","volume":"84","author":"Yasuda","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2017.06.004_bb0410","first-page":"687","article-title":"Abundance of cytochromes P450 in human liver","volume":"57","author":"Yeo","year":"2004","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Environment International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0160412017301204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0160412017301204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:29:49Z","timestamp":1758972589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0160412017301204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":84,"alternative-id":["S0160412017301204"],"URL":"https:\/\/doi.org\/10.1016\/j.envint.2017.06.004","relation":{},"ISSN":["0160-4120"],"issn-type":[{"value":"0160-4120","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying populations sensitive to environmental chemicals by simulating toxicokinetic variability","name":"articletitle","label":"Article Title"},{"value":"Environment International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.envint.2017.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}